Current Advance of Immune Evasion Mechanisms and Emerging Immunotherapies in Renal Cell Carcinoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current Advance of Immune Evasion Mechanisms and Emerging Immunotherapies in Renal Cell Carcinoma
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-03-09
DOI
10.3389/fimmu.2021.639636
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Acute Kidney Injury after CAR-T Cell Therapy: Low Incidence and Rapid Recovery
- (2020) Victoria Gutgarts et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- LAG3(LAG-3,CD223) DNA methylation correlates with LAG3 expression by tumor and immune cells, immune cell infiltration, and overall survival in clear cell renal cell carcinoma
- (2020) Niklas Klümper et al. Journal for ImmunoTherapy of Cancer
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Patient-reported outcomes of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib (CheckMate 214): a randomised, phase 3 trial
- (2019) David Cella et al. LANCET ONCOLOGY
- High Expression of HLA-G in Ovarian Carcinomatosis: The Role of Interleukin-1β
- (2019) Matti Ullah et al. NEOPLASIA
- Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
- (2019) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
- (2019) Brian I. Rini et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular Interactions of Antibody Drugs Targeting PD-1, PD-L1, and CTLA-4 in Immuno-Oncology
- (2019) Hyun Lee et al. MOLECULES
- Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial
- (2019) Bas D. Koster et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Differential expressions of PD-1, PD-L1 and PD-L2 between primary and metastatic sites in renal cell carcinoma
- (2019) Xingming Zhang et al. BMC CANCER
- Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial
- (2019) Brian I Rini et al. LANCET
- Physiological and pathological levels of prostaglandin E2 in renal parenchyma and neoplastic renal tissue
- (2019) Vittore Verratti et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- VEGF Impairs the Motility and Immune Function of Human Mature Dendritic Cells through VEGFR 2‐RhoA‐Cofilin1 Pathway
- (2019) Jinhua Long et al. CANCER SCIENCE
- Role of Regulatory B Cells in the Progression of Cervical Cancer
- (2019) Zhifang Chen et al. MEDIATORS OF INFLAMMATION
- Regulatory T Cells Promote Overexpression of Lgr5 on Gastric Cancer Cells via TGF-beta1 and Confer Poor Prognosis in Gastric Cancer
- (2019) Xiao-Sun Liu et al. Frontiers in Immunology
- Characterization of intratumoral and circulating IL-10-producing B cells in gastric cancer
- (2019) Hong-Tao Hu et al. EXPERIMENTAL CELL RESEARCH
- CAIX-specific CAR-T Cells and Sunitinib Show Synergistic Effects Against Metastatic Renal Cancer Models
- (2019) Huizhong Li et al. JOURNAL OF IMMUNOTHERAPY
- Biomarkers of Prognosis and Efficacy of Anti-angiogenic Therapy in Metastatic Clear Cell Renal Cancer
- (2019) Carmine D'Aniello et al. Frontiers in Oncology
- Integrin Activation Controls Regulatory T Cell–Mediated Peripheral Tolerance
- (2018) Jane E. Klann et al. JOURNAL OF IMMUNOLOGY
- Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial
- (2018) Michael B Atkins et al. LANCET ONCOLOGY
- Preliminary results for avelumab plus axitinib as first-line therapy in patients with advanced clear-cell renal-cell carcinoma (JAVELIN Renal 100): an open-label, dose-finding and dose-expansion, phase 1b trial
- (2018) Toni K Choueiri et al. LANCET ONCOLOGY
- Vascular endothelial growth factor suppresses dendritic cells function of human prostate cancer
- (2018) Wen-kun Bai et al. OncoTargets and Therapy
- The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non–Clear Cell Renal Cell Carcinoma
- (2018) Rana R. McKay et al. Cancer Immunology Research
- Pembrolizumab for the first-line treatment of non-small cell lung cancer
- (2018) Kiichiro Ninomiya et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Bortezomib improves adoptive carbonic anhydrase�IX‑specific chimeric antigen receptor‑modified NK92 cell therapy in mouse models of human renal cell carcinoma
- (2018) Qing Zhang et al. ONCOLOGY REPORTS
- Myeloid-derived suppressor cells inhibit T cell activation through nitrating LCK in mouse cancers
- (2018) Shan Feng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prostaglandin E2 Secreted by Thyroid Cancer Cells Contributes to Immune Escape Through the Suppression of Natural Killer (NK) Cell Cytotoxicity and NK Cell Differentiation
- (2018) Arum Park et al. Frontiers in Immunology
- Tumor-associated Macrophage-derived Interleukin-23 Interlinks Kidney Cancer Glutamine Addiction with Immune Evasion
- (2018) Qiang Fu et al. EUROPEAN UROLOGY
- New and emerging renal entities: a perspective post-WHO 2016 classification
- (2018) Kiril Trpkov et al. HISTOPATHOLOGY
- The Cytokine TGF-β Promotes the Development and Homeostasis of Alveolar Macrophages
- (2017) Xueyang Yu et al. IMMUNITY
- Safety and Efficacy of Nivolumab in Combination With Ipilimumab in Metastatic Renal Cell Carcinoma: The CheckMate 016 Study
- (2017) Hans J. Hammers et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma
- (2017) Robert Chen et al. JOURNAL OF CLINICAL ONCOLOGY
- Macrophages induce EMT to promote invasion of lung cancer cells through the IL-6-mediated COX-2/PGE 2 /β-catenin signalling pathway
- (2017) Dehai Che et al. MOLECULAR IMMUNOLOGY
- Regulation of the Immune Response by TGF-β: From Conception to Autoimmunity and Infection
- (2017) Shomyseh Sanjabi et al. Cold Spring Harbor Perspectives in Biology
- IL-12p35 induces expansion of IL-10 and IL-35-expressing regulatory B cells and ameliorates autoimmune disease
- (2017) Ivy M. Dambuza et al. Nature Communications
- Negative regulation of tumor-infiltrating NK cell in clear cell renal cell carcinoma patients through the exosomal pathway
- (2017) Yang Xia et al. Oncotarget
- Treatment Outcome of Low-dose Interleukin-2 Therapy in Patients with Metastatic Renal Cell Carcinoma
- (2016) YUTA TAKEZAWA et al. ANTICANCER RESEARCH
- Treatment of metastatic renal cell carcinoma (mRCC) with CAIX CAR-engineered T-cells-a completed study overview
- (2016) C. H. J. Lamers et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Myeloid-Derived Suppressor Cell Subset Accumulation in Renal Cell Carcinoma Parenchyma Is Associated with Intratumoral Expression of IL1β, IL8, CXCL5, and Mip-1α
- (2016) Yana G. Najjar et al. CLINICAL CANCER RESEARCH
- The absence of HLA class I expression in non-small cell lung cancer correlates with the tumor tissue structure and the pattern of T cell infiltration
- (2016) Francisco Perea et al. INTERNATIONAL JOURNAL OF CANCER
- Atezolizumab, an Anti–Programmed Death-Ligand 1 Antibody, in Metastatic Renal Cell Carcinoma: Long-Term Safety, Clinical Activity, and Immune Correlates From a Phase Ia Study
- (2016) David F. McDermott et al. JOURNAL OF CLINICAL ONCOLOGY
- IMA901, a multipeptide cancer vaccine, plus sunitinib versus sunitinib alone, as first-line therapy for advanced or metastatic renal cell carcinoma (IMPRINT): a multicentre, open-label, randomised, controlled, phase 3 trial
- (2016) Brian I Rini et al. LANCET ONCOLOGY
- CXCL2/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer
- (2016) H Zhang et al. ONCOGENE
- CD19+IL-10+ regulatory B cells affect survival of tongue squamous cell carcinoma patients and induce resting CD4+ T cells to CD4+Foxp3+ regulatory T cells
- (2016) Xi Zhou et al. ORAL ONCOLOGY
- Cancer immunotherapy targeting neoantigens
- (2016) Yong-Chen Lu et al. SEMINARS IN IMMUNOLOGY
- Myeloid-derived suppressor cells and tumor escape from immune surveillance
- (2016) Viktor Umansky et al. Seminars in Immunopathology
- The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
- (2016) Vinit Kumar et al. TRENDS IN IMMUNOLOGY
- Transforming growth factor beta (TGF-β) isoforms in wound healing and fibrosis
- (2016) Michael K. Lichtman et al. WOUND REPAIR AND REGENERATION
- Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma
- (2016) Jeffrey J. Wallin et al. Nature Communications
- Suppressive role of myeloid-derived suppressor cells (MDSCs) in the microenvironment of breast cancer and targeted immunotherapies
- (2016) Dawei Shou et al. Oncotarget
- HLA-E expression and its clinical relevance in human renal cell carcinoma
- (2016) Barbara Seliger et al. Oncotarget
- Adjuvants for peptide-based cancer vaccines
- (2016) Hiep Khong et al. Journal for ImmunoTherapy of Cancer
- Adoptive T-cell therapy: a need for standard immune monitoring
- (2015) Yarne Klaver et al. Immunotherapy
- Regulatory B cells in anti-tumor immunity
- (2015) Yu Zhang et al. INTERNATIONAL IMMUNOLOGY
- Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial
- (2015) Robert J. Motzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Tr1 Cells, but Not Foxp3+Regulatory T Cells, Suppress NLRP3 Inflammasome Activation via an IL-10–Dependent Mechanism
- (2015) Yu Yao et al. JOURNAL OF IMMUNOLOGY
- Exosomal Hsp70 mediates immunosuppressive activity of the myeloid-derived suppressor cells via phosphorylation of Stat3
- (2015) Jianjun Diao et al. MEDICAL ONCOLOGY
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab versus Ipilimumab in Advanced Melanoma
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting the TGFβ pathway for cancer therapy
- (2015) Cindy Neuzillet et al. PHARMACOLOGY & THERAPEUTICS
- Interleukin 10-expressing B cells inhibit tumor-infiltrating T cell function and correlate with T cell Tim-3 expression in renal cell carcinoma
- (2015) Chen Cai et al. TUMOR BIOLOGY
- Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti-PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor Cells
- (2015) B. Boyerinas et al. Cancer Immunology Research
- Survival with AGS-003, an autologous dendritic cell–based immunotherapy, in combination with sunitinib in unfavorable risk patients with advanced renal cell carcinoma (RCC): Phase 2 study results
- (2015) Asim Amin et al. Journal for ImmunoTherapy of Cancer
- Sweet escape: Sialic acids in tumor immune evasion
- (2014) Christian Büll et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- The role of prostaglandin E2 in renal cell cancer development: future implications for prognosis and therapy
- (2014) Katarzyna Kaminska et al. Future Oncology
- Regulatory T-cell homeostasis: steady-state maintenance and modulation during inflammation
- (2014) Kate S. Smigiel et al. IMMUNOLOGICAL REVIEWS
- Adjuvant Low-Dose Interleukin-2 (IL-2) Plus Interferon-α (IFN-α) in Operable Renal Cell Carcinoma (RCC)
- (2014) Rodolfo Passalacqua et al. JOURNAL OF IMMUNOTHERAPY
- Isolinderalactone inhibits proliferation of A549 human non-small cell lung cancer cells by arresting the cell cycle at the G0/G1 phase and inducing a Fas receptor and soluble Fas ligand-mediated apoptotic pathway
- (2014) WEI-AN CHANG et al. Molecular Medicine Reports
- Implicación de las moléculas HLA de clase I en el escape inmunitario de tumores urológicos
- (2013) R. Carretero et al. Actas Urologicas Espanolas
- B cells and their mediators as targets for therapy in solid tumors
- (2013) Andrew J. Gunderson et al. EXPERIMENTAL CELL RESEARCH
- Immunosuppressive effect of renal cell carcinoma on phenotype and function of dendritic cells
- (2013) Lichen Teng et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- The Ratios of CD8+ T Cells to CD4+CD25+ FOXP3+ and FOXP3- T Cells Correlate with Poor Clinical Outcome in Human Serous Ovarian Cancer
- (2013) Claudia C. Preston et al. PLoS One
- B7-H3 is a new cancer-specific endothelial marker in clear cell renal cell carcinoma
- (2013) Xiao Qin et al. OncoTargets and Therapy
- B cell-regulated immune responses in tumor models and cancer patients
- (2013) Carlo Fremd et al. OncoImmunology
- Induced expression of B7-H3 on the lung cancer cells and macrophages suppresses T-cell mediating anti-tumor immune response
- (2012) Cheng Chen et al. EXPERIMENTAL CELL RESEARCH
- Diverse Roles of TGF-β/Smads in Renal Fibrosis and Inflammation
- (2012) Hui Yao Lan International Journal of Biological Sciences
- Activated T Cell Exosomes Promote Tumor Invasion via Fas Signaling Pathway
- (2012) Z. Cai et al. JOURNAL OF IMMUNOLOGY
- Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
- (2012) Steffen Walter et al. NATURE MEDICINE
- The role of classical and non-classical HLA class I antigens in human tumors
- (2012) Juergen Bukur et al. SEMINARS IN CANCER BIOLOGY
- The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis
- (2011) M J M Gooden et al. BRITISH JOURNAL OF CANCER
- Induced expression of B7-H4 on the surface of lung cancer cell by the tumor-associated macrophages: A potential mechanism of immune escape
- (2011) Cheng Chen et al. CANCER LETTERS
- Tumor-Associated Macrophages Mediate Immunosuppression in the Renal Cancer Microenvironment by Activating the 15-Lipoxygenase-2 Pathway
- (2011) I. Daurkin et al. CANCER RESEARCH
- Tumor-Evoked Regulatory B Cells Promote Breast Cancer Metastasis by Converting Resting CD4+ T Cells to T-Regulatory Cells
- (2011) P. B. Olkhanud et al. CANCER RESEARCH
- Hypoxia, tumour-associated macrophages, microvessel density, VEGF and matrix metalloproteinases in human gastric cancer: interaction and impact on survival
- (2011) Sergej Osinsky et al. Clinical & Translational Oncology
- New Insights into the Biology of Renal Cell Carcinoma
- (2011) Lianjie Li et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Regulation of Immune Responses by Prostaglandin E2
- (2011) P. Kalinski JOURNAL OF IMMUNOLOGY
- Altered HLA Class I and HLA-G Expression Is Associated with IL-10 Expression in Patients with Cervical Cancer
- (2011) Josefa Antonia Rodríguez et al. PATHOBIOLOGY
- Frequency of regulatory T cells in peripheral blood and in tumour-infiltrating lymphocytes correlates with poor prognosis in renal cell carcinoma
- (2010) Francesco Liotta et al. BJU INTERNATIONAL
- Human breast tumor cells express IL-10 and IL-12p40 transcripts and proteins, but do not produce IL-12p70
- (2010) Mark C. Heckel et al. CELLULAR IMMUNOLOGY
- Vaccination of Metastatic Renal Cancer Patients with MVA-5T4: A Randomized, Double-Blind, Placebo-Controlled Phase III Study
- (2010) R. J. Amato et al. CLINICAL CANCER RESEARCH
- Systemic Immune Tuning in Renal Cell Carcinoma
- (2010) Antonia Busse et al. JOURNAL OF IMMUNOTHERAPY
- High-dose Interleukin-2 Can Produce a High Rate of Response and Durable Remissions in Appropriately Selected Patients With Metastatic Renal Cancer
- (2010) Alaaeldin Shablak et al. JOURNAL OF IMMUNOTHERAPY
- The Effects of the Stromal Cell-Derived Cyclooxygenase-2 Metabolite Prostaglandin E2 on the Proliferation of Colon Cancer Cells
- (2010) S.-W. Park et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Renal cell carcinoma may evade the immune system by converting CD4+Foxp3- T cells into CD4+CD25+Foxp3+ regulatory T cells: Role of tumor COX-2-derived PGE2
- (2010) Wang Molecular Medicine Reports
- CD95 promotes tumour growth
- (2010) Lina Chen et al. NATURE
- A clinical phase I/II trial with the monoclonal antibody cG250 (RENCAREX®) and interferon-alpha-2a in metastatic renal cell carcinoma patients
- (2010) M. Siebels et al. WORLD JOURNAL OF UROLOGY
- Phase II Trial of B7-1 (CD-86) Transduced, Cultured Autologous Tumor Cell Vaccine Plus Subcutaneous Interleukin-2 for Treatment of Stage IV Renal Cell Carcinoma
- (2009) Mayer Fishman et al. JOURNAL OF IMMUNOTHERAPY
- Vaccination of Renal Cell Cancer Patients With Modified Vaccinia Ankara Delivering the Tumor Antigen 5T4 (TroVax) Alone or Administered in Combination With Interferon-α (IFN-α)
- (2009) Robert J. Amato et al. JOURNAL OF IMMUNOTHERAPY
- HIF1α Induces the Recruitment of Bone Marrow-Derived Vascular Modulatory Cells to Regulate Tumor Angiogenesis and Invasion
- (2008) Rose Du et al. CANCER CELL
- Vaccination of Renal Cell Cancer Patients with Modified Vaccinia Ankara Delivering Tumor Antigen 5T4 (TroVax) Administered with Interleukin 2: A Phase II Trial
- (2008) R. J. Amato et al. CLINICAL CANCER RESEARCH
- Regulatory T Cell-Derived Interleukin-10 Limits Inflammation at Environmental Interfaces
- (2008) Yuri P. Rubtsov et al. IMMUNITY
- Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives
- (2008) Paulo C. Rodríguez et al. IMMUNOLOGICAL REVIEWS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More